🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Leading experts and industry professionals left Neuro2024: The PSP and CBD International Research Symposium, hosted by CurePSP in partnership with the Rossy PSP Centre, with an increased enthusiasm for PSP and CBD research. More on the sold-out event: psp.org/news/details/l…

It is an incredible honour to have been nominated for and to have received this wonderful award. Many thanks to WiNUK: Women in Neuroscience UK 🧠 and the British Neuroscience Association - and to my lab of brilliant dementia scientists who are such a joy to work with!

Had a great time in Cambridge thanks to the AFI foundation! Amazing research and pub culture with the Maura Malpetti lab - can’t wait to return next year with the Thiemann Foundation

This #GivingTuesday, we are honored to highlight Dr. Maura Malpetti and her unwavering commitment to our community. Donate today and help us reach out goal! give.curepsp.org/campaign/63806…

🚨Our latest pre-print is now available on medRxiv!🚨 medrxiv.org/content/10.110… We studied 1,402 patients to comprehensively assess the diagnostic + prognostic value of alpha-synuclein seed amplification assay in Parkinson’s disease. See below for our main findings (1/14)

Wrapping up a year that exceeded all my expectations, I feel very grateful for this wonderful team, the bigger family at Cambridge FTD, all collaborators, participants and families, and funders for a 2024 full of wonderful science, growth, and enthusiasm! More to come in 2025!

Always my favourite post at the beginning of the year: Registration for our course “Biomarkers for neurodegenerative diseases” is now open! This year’s edition takes place at UCL Queen Square Institute of Neurology in central London on May 12-16. biomarker-course.org

Dr. Maura Malpetti and her team at the University of Cambridge have identified brain inflammation as a key contributor to disease progression, and are developing a blood test for inflammation that will help track the effectiveness of clinical trials: psp.org/podcast/episod…

🧠 Join us for an insightful #webinar on The Basics of Neuropathology in Frontotemporal Lobar Degeneration (#FTLD): Human Postmortem Evidence 🏥🔬 📅 March 10, 2025 11:00 a.m. CT (USA) 🔗 Register now: alz.org/research-webin… #DementiaResearch #FTD #Neuropathology #ISTAART

Today is International Day of Women & Girls in Science! We've teamed up with Race Against Dementia to spotlight 3 incredible scientists working across our organisations👏 @aitanasogorb Maura Malpetti & @ClaireDurrant1 discuss their biggest ambitions & who inspires

It is amazing to be back in this beautiful corner of the world for a research visit at the UCSF MAC, working with the RabLab! Looking forward to (re)connecting with old friends and new collaborators in the next few months!

It is amazing to be back in this beautiful corner of the world for a research visit at the UCSF MAC, working with the RabLab! Looking forward to (re)connecting with old friends and new collaborators in the next few months!

Congratulations to Maura Malpetti and her team working on the On-FIRE project. It is an associated study which exemplifies how @DementiasPlatform can help to deliver great dementia research.

Why academia is sleepwalking into self-destruction. My editorial Brain If you agree with the sentiments please RT. It's important for all our sakes to stop the madness academic.oup.com/brain/issue/14…

Thank you to everyone who joined our webinar. And special thanks to our four expert speakers Maura Malpetti CarmelaTartaglia Lea T. Grinberg, M.D, Ph.D and Shelley Forrest for sharing their insights on FTLD pathology and its implications for research and clinical practice. Stay tuned for more events!